Amarin (AMRN)
(Delayed Data from NSDQ)
$0.86 USD
-0.02 (-2.11%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $0.86 0.00 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AMRN 0.86 -0.02(-2.11%)
Will AMRN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AMRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMRN
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe
Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
AMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Rising Operating Costs Affect Acadia's (ACHC) Q4 Earnings?
Can Higher Admissions Drive Universal Health (UHS) Q4 Earnings?
Aquestive (AQST) to Report Q4 Earnings: Here's What to Expect
Other News for AMRN
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
12 Health Care Stocks Moving In Wednesday's After-Market Session
ArriVent Appoints Kristine Peterson to its Board of Directors
Amarin Shareholders Show Strong Support at Annual Meeting
Amarin Announces Results of Annual General Meeting of Shareholders